首页> 外文期刊>Cancer Management and Research >Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
【24h】

Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma

机译:新诊断的结外自然杀伤/ T细胞淋巴瘤患者外周血绝对淋巴细胞计数和中性白细胞与淋巴细胞比例的预后意义

获取原文
       

摘要

Background: Accumulating evidence suggested that tumor microenvironment and host immune system played important roles in determining the clinical course and outcome of human malignancies. The derived neutrophil to lymphocyte ratio (dNLR) and absolute lymphocyte count (ALC) were demonstrated to act as a prognostic factor in several malignancies. Nevertheless, the prognostic significance of them in extranodal natural killer/T-cell lymphoma (ENKTL) patients has never been explored. Patients and methods: A total of 33 newly diagnosed patients with ENKTL were included in this study. Clinicopathological characteristics were collected and prognostic significance of dNLR and ALC were evaluated. Results: Elevated dNLR and low ALC were both associated with poor survival rates. Patients with dNLR ≥3.6 revealed significantly shorter overall survival (OS) ( P =0.001) and progression-free survival (PFS) ( P =0.008) than those with dNLR 9,/L had worse OS ( P =0.008) and PFS ( P 0.001) than those with ALC ≥0.8×10sup9,/sup/L. An independent significant association between low ALC and poor clinical outcome in multivariate analysis for OS (HR, 36.023; 95% CI, 2.438–532.243; P =0.009) as well as PFS (HR, 7.698; 95%CI, 1.573–37.679; P =0.012) was identified. Conclusion: In this study, we validated for the first time the prognostic value of dNLR and ALC in ENKTL patients. Elevated dNLR and low ALC were both associated with aggressive tumor process and poor survival.ALC value at diagnosis represented an independent favorable prognostic factor for the clinical outcome of ENKTL patients.
机译:背景:越来越多的证据表明,肿瘤微环境和宿主免疫系统在决定人类恶性肿瘤的临床进程和结果中起着重要作用。已证明衍生的嗜中性白细胞与淋巴细胞之比(dNLR)和绝对淋巴细胞计数(ALC)可作为多种恶性肿瘤的预后因素。然而,从未探讨过它们在结外自然杀伤/ T细胞淋巴瘤(ENKTL)患者中的预后意义。患者和方法:本研究共纳入33名新诊断的ENKTL患者。收集临床病理特征并评估dNLR和ALC的预后意义。结果:dNLR升高和ALC低均与不良的生存率有关。 dNLR≥3.6的患者显示总生存期(OS)(P = 0.001)和无进展生存期(PFS)(P = 0.008)比dNLR 9 / L的OS差(P = 0.008)和PFS( P <0.001),而ALC≥0.8×10 9, / L。在OS多变量分析(HR,36.023; 95%CI,2.438-532.243; P = 0.009)和PFS(HR,7.698; 95%CI,1.573-37.679; P = 0.012)。结论:在这项研究中,我们首次验证了dNLR和ALC在ENKTL患者中的预后价值。 dNLR升高和ALC降低均与侵袭性肿瘤进程和不良生存有关。诊断时的ALC值代表ENKTL患者临床预后的独立有利预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号